Universe Pharmaceuticals (NASDAQ: UPC) CEO receives share grants under 2026 equity plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lai Gang reported acquisition or exercise transactions in this Form 4 filing.
Universe Pharmaceuticals CEO Gang Lai reported new share grants in Universe Pharmaceuticals INC. On May 7, 2026, he received 12,610 Class B ordinary shares and 71,890 Class A ordinary shares at $0.0000 per share as a grant or award.
Footnotes state these ordinary shares were granted under the company’s 2026 Equity Incentive Plan in consideration for past services and are governed by an award agreement dated May 5, 2026. After the transactions, Lai directly holds 12,610 Class B shares and 71,890 Class A shares, and indirectly holds 3,467 Class B shares through Sununion Holding Group Limited.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Lai Gang
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A ordinary shares, par value US$0.00001 per share | 71,890 | $0.00 | -- |
| Grant/Award | Class B ordinary shares, par value US$0.00001 per share | 12,610 | $0.00 | -- |
| holding | Class B ordinary shares, par value US$0.00001 per share | -- | -- | -- |
Holdings After Transaction:
Class A ordinary shares, par value US$0.00001 per share — 71,890 shares (Direct, null);
Class B ordinary shares, par value US$0.00001 per share — 12,610 shares (Direct, null);
Class B ordinary shares, par value US$0.00001 per share — 3,467 shares (Indirect, By Sununion Holding Group Limited)
Footnotes (1)
- Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person. The grant is subject to the terms of an award agreement entered into by and between the Reporting Person and the Issuer, dated May 5, 2026. Represents 3,467 Class B ordinary shares held by Sununion Holding Group Limited, a business company incorporated in the British Virgin Islands, which is owned as to 100% and controlled by Gang Lai. The registered address of Sununion Holding Group Limited is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands.
Key Figures
Class B shares granted: 12,610 shares
Class A shares granted: 71,890 shares
Grant price per share: $0.0000 per share
+3 more
6 metrics
Class B shares granted
12,610 shares
Grant of Class B ordinary shares on May 7, 2026
Class A shares granted
71,890 shares
Grant of Class A ordinary shares on May 7, 2026
Grant price per share
$0.0000 per share
Price for both Class A and Class B grants
Indirect Class B holdings
3,467 shares
Class B shares held via Sununion Holding Group Limited
Direct Class B holdings after grant
12,610 shares
Total Class B ordinary shares directly held after grant
Direct Class A holdings after grant
71,890 shares
Total Class A ordinary shares directly held after grant
Key Terms
2026 Equity Incentive Plan, Rule 16b-3, Class B ordinary shares, Class A ordinary shares, +1 more
5 terms
2026 Equity Incentive Plan financial
"Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3"
Rule 16b-3 regulatory
"in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
FAQ
What did Universe Pharmaceuticals (UPC) CEO Gang Lai report on this Form 4?
The Form 4 shows CEO Gang Lai received grants of Class A and Class B ordinary shares. These were compensation-related awards under the 2026 Equity Incentive Plan, not open-market purchases or sales, and reflect additional equity-based pay for past services.
What indirect Universe Pharmaceuticals holdings does Gang Lai report on this Form 4?
The Form 4 shows 3,467 Class B ordinary shares held indirectly through Sununion Holding Group Limited. The footnote explains Sununion is a British Virgin Islands company owned and controlled 100% by Gang Lai, which holds these Class B shares.